Tuesday, 15 January 2019

Connective Tissue Disease Market Profound Impact on the Market by Growing Healthcare Sector during the Forecast Period 2018-2023

Developments in the treatment of connective tissue diseases (CTDs) have been improved considerably, and the global connective tissue diseases market is slated to grow at a promising CAGR of 11.5% over the forecast period of 2017-2023. The cause of the disease is unknown and there's no cure for connective tissue disease yet, but medications are present to manage the signs and symptoms. CTDs include a large number of disorders which can affect different organs of the body. There is broad variability in disorders among patient suffering from CTDs.
It is estimated that connective tissue disease market is expected to grow at a CAGR 11.5% during the forecast period of 2017-2023.
A significant increase in the research and development efforts to find treatment and cure for CTDs have aided the growth of the market. Various therapy trials are underway which have been able to identify promising novel approaches to treat CTDs and are expected to boost the growth of the market. Rising prevalence of CTDs across the globe, especially in women has propelled the growth of the market. Additionally, support from governments across the world along with funds for R&D from the private industry is also a key driver of the growth of the market. With the increase in awareness and acceptance among the general population about connective tissue diseases, the diagnosed and drug-treated population will increase which will positively impact the market. Rising expenditure on healthcare, high unmet medical needs of the current treatment and growing prevalence of CTDs in Asia and Africa are expected to promote the growth of the market.  However, the growth of the market might be hindered by lack of a knowledgeable workforce, inadequate research and development infrastructure, lack of funds in middle and low-income countries.
Regional Analysis
The Americas dominate the connective tissue disease market owing to the rising awareness among people, and increasing healthcare expenditure. As per the facts suggested by the Centers for Disease Control and Prevention (CDC), out of the total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States.
Europe holds the second position in the connective tissue disease market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe.
Asia Pacific is the fastest growing market connective tissue disease, owing to a huge patient pool, developing healthcare technology, and rising healthcare expenditure in some countries within this region. According to the Australian Institute of Health and Welfare, in the years 2015 to 2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than expenditure of 2014–15.
The Middle East & Africa has the lowest market for connective tissue disease due to lack of technical knowledge and poor medical facilities. 
Key Players
Some of key the players in the market are Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche Ltd, Pfizer, AutoImmune Inc., Johnson & Johnson, Amgen Inc., AstraZeneca, Eli Lilly and Company, Biogen, LUPIN, and others.
Segmentation
The connective tissue disease market is segmented on the basis of diagnosis, treatment, and end-user.
On the basis of diagnosis, market is segmented into physical examination, X-ray examination, ANA (Antinuclear Antibody Test), and others.
On the basis of treatment, market is classified into non-steroidal anti-inflammatory drugs (NSAIDs), cortisone drugs/steroids, antimalarial drugs, cytotoxic drugs, and others
On the basis of end-user, market is segmented into hospital, diagnostic clinics, and others.

Browse Complete 85  Pages Premium Research Report Enabled with 66 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/connective-tissue-disease-market-4977
Detailed Table of Contents:
  1. Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
  1. Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research
  1. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
...Continued!
         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Laser Probe Market 2018 Competitive Analysis, Segmentation, Industry Highlights and Forecasts Till 2023

Market Scenario:
As per the analysis published by Market Research Future (MRFR), the global laser probe market is set to strike a CAGR of 9.11% during the forecast period 2018 to 2023. The valuation of the market is estimated to reach USD 1560.76 Mn by the end of 2023. The developments in the laser probe technology have paved its way across a wide spectrum of applications. Investments directed towards the technological innovations are prognosticated to boost the growth trajectory of the market.
The rising burden of chronic diseases such as diabetic retinopathy, non-melanoma skin cancer, barrette’s esophagus, prostate cancer, etc. have encouraged the governments and key players to accelerate research and funding. This, in turn, is likely to have a positive influence on the expansion of the laser probe market over the next couple of years.
Synopsis:
The improvements introduced in the reimbursement protocols have unleashed promising opportunities and are presumed to dominate the growth of the market in the foreseeable future. On the flip side, availability of alternative diagnostic techniques remains an impediment to the expansion of the global laser probe market.
Report Overview:
This MRFR report offers a five-year (2018 to 2023) foresight for the global laser probe market. The product types profiled for revenue assessment of the market covers Continuous-Wave (CW) laser probe and pulse laser probe. Furthermore, the probe types included in the study encompasses single laser probe and cluster laser probe. For market sizing, the applications such as ophthalmology, dermatology, rheumatology, orthopedics, and dentistry have been profiled. The key end-users identified in the report are tertiary hospitals and clinics. A detailed geographical analysis of the global laser probe market spans across Americas, Europe, Asia Pacific, and the Middle East & Africa.
Report Coverage:
This MRFR report covers a detailed assessment of historical trends, market dynamics, forecast, and key players’ market share analysis. It also includes market factor analysis which encompasses Porter’s five forces analysis and supply chain analysis. An in-depth study of the laser probe market by region as well as segmentation along with a country-level analysis of each segment is also available in the report.
Companies Covered:
Some of the key players operating in the global laser probe market are Alcon (Novartis), Bausch & Lomb Incorporated, FCI, Omega Laser Systems Limited, Reimers & Janssen GmbH, ADInstruments, Transonic Systems Inc., Lumenis, OphthalMed LLC, Vitreq, Iridex Corporation, and Quantel Medical.
Research Methodology:
MRFR strives to leverage its robust, cutting-edge data tools for the extrapolation of a reliable market foresight. Fail-safe methodologies are utilized for the interpretation of data collected from primary and secondary research into actionable insights. Sources referred for data curation include interviews with top-notch executives, surveys, questionnaires, SEC filings, whitepaper references, paid database services, annual published reports, etc. A multi-layer verification process ensures the credibility of the information offered for shedding light on the future trajectory of the laser probe market. In addition, top-down and bottom-up approaches employed authenticate the accuracy of the statistical observations available in the report.
Segmental Analysis:
Product Type:
  • Continuous-Wave (CW) Laser Probe
  • Pulse Laser Probe
Probe Type:
  • Single Laser Probe
  • Cluster laser probe
Application:
  • Ophthalmology
  • Dermatology
  • Rheumatology
  • Orthopedics
  • Dentistry
End-User:
  • Tertiary Hospitals
  • Clinics
Region:
  • Americas
  • Europe
  • Asia Pacific
  • Middle East & Africa
 Browse Complete 120 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/laser-probe-market-7009

Detailed Table of Contents for Laser Probe Market
  1. Report Prologue
  2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
  1. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
  1. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
...Continued!

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Monday, 14 January 2019

Pemphigus Vulgaris Market Segmentation Detailed Study with Forecast Up To 2018

Market Scenario:
Pemphigus vulgaris is a type of autoimmune disease, and the most common among the pemphigus group diseases. Pemphigus vulgaris is the most common type of pemphigus disease in the United States and has an incidence of 0.5-3.2 per 100,000 worldwide. It results in painful lesions on the mucous membranes of the body, which exist in the mouth, nose, throat, eyes, lungs, and genitals. The disease usually starts out in the mucous membranes on the inside of the mouth and spreads to the neck, face, scalp, and back. The armpits and the genitalia may also be affected by pemphigus vulgaris. The inside of the cheeks, the palate, the tongue, and the lips are often the most affected areas. Pemphigus vulgaris lesions can also spread to join up with each other, creating much larger lesions that spread across the whole face and make it difficult and painful to swallow.
The global pemphigus vulgaris market was valued at USD 289.3 million in 2017 and is likely to rise to a valuation of USD 677.99 million by 2027 at an 8% CAGR through the forecast period (2018-2027). It can grow rapidly in the last few decades, following the discovery of the effectiveness of corticosteroids and immunosuppressants in curbing the disease. Before this discovery, in the 1950s, pemphigus vulgaris had a death rate of almost 75%. The introduction of modern medicine and early diagnostic procedures has also had a major impact on the mortality of the disease, thus driving the pemphigus vulgaris market.
Report Overview
The global pemphigus vulgaris market is analyzed in terms of the overall structure of the market as well as the share of the leading segments in the market and their likely role in the market’s progression in the coming years. To this end, the top-down as well as bottom-up approach is utilized to study the global pemphigus vulgaris market. The market is segmented by various criteria in order to understand the granular structure of the market in great detail. The competitive landscape of the market is also explained in the report in order to familiarize the readers with the profile of the leading players in the market as well as to offer solutions as to making the most of the opportunities in the global pemphigus vulgaris market and overcoming the competition in the market.
Segmentation Overview
The global pemphigus vulgaris market is segmented on the basis of treatment, route of administration, end use, and region. By treatment type, the pemphigus vulgaris market is segmented into corticosteroids, immunosuppressants, biological therapies, and intravenous immunoglobulin. By route of administration, the pemphigus vulgaris market is segmented into intravenous, subcutaneous, and oral. By end use, the market is segmented into hospitals and clinics, specialty dermatology clinics, and research and academic laboratories. By region, the pemphigus vulgaris market is segmented into the Americas, Europe, Asia Pacific, and Rest-of-the-World (RoW).
Research Methodology
The report uses detailed information gathered from primary as well as secondary sources to present a comprehensive picture of the global market. Secondary research from validated, trustworthy sources is used to back up information gathered from primary interviews with key players in the pemphigus vulgaris market. Gathering accurate data has been the primary objective of the analysts working on this report, while strong, reliable analysis tools are used to make sense of the data and derive useful, precise projections regarding the market’s future. Extensive information about the pemphigus vulgaris market’s past development path has been used to derive accurate projections about the market’s future.
Competitive Analysis
Leading players operating in the global pemphigus vulgaris market are studied in order to present readers with a clear picture of the competitive goings on in the market. The top strategies for success in the market are also elaborated upon so that players can formulate well-informed plans to make the most of their opportunities in the pemphigus vulgaris market. Leading players in the global pemphigus vulgaris market include Almirall SA (Spain), Biogen Inc. (U.S.), Argenx SE (Belgium), F. Hoffman-La Roche (Switzerland), Pfizer Inc. (U.S.), Syntimmune (India), Novartis AG (Switzerland), Janssen Global Services LLC (U.S.), Sanofi (France), and Principia Biopharma (U.S.).
Browse Complete 120 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/pemphigus-vulgaris-market-6870

Detailed Table of Contents for Pemphigus Vulgaris Market
  1. Report Prologue
  2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
  1. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
  1. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
...Continued!

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Surgical Retractors Market Analysis 2018 (By Segment, Key Players and Applications) and Forecasts To 2023

Market Scenario:

Global Surgical Retractors Market is expected to grow significantly over the forecast period. The market held a market value of USD 1,103 million in 2017 and is projected to grow at a CAGR of 7.8% over the forecast period.
Retractors is surgical instrument which is used to separate the edges of the wound or surgical incision.
The factors such as increasing number of surgical procedures is the major driving factor for the market. Beside this technological advances and improved surgical treatment with increased success rate has provided fuel for the growth of the market. Cost of surgery and surgical products may restrain the growth of the market.
According to WHO, in 2015, more than 35% of the total global population were suffering from major or minor cardiovascular complication and in 2014, globally 39% of adults aged 18 years and over were overweight whereas 13% were obese.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/7019            
Segmentation:The Global Surgical Retractors Market has been segmented into product type, design, product usage, application, and end user. By product type, the market has been segmented into hand retractors, self-retaining retractors, table-mounted retractors, wire retractors, and accessories.Based on design, the market has been segmented into fixed or flat frame retractors, angled or curved frame retractors, and blade or elevated-tipped retractors. Based on product usage, the market has been segmented into tissue handling and dissection and fluid swabbing.
Based on application, the market has been segmented into obstetric & gynaecological, urological, abdominal, cardiothoracic, orthopaedic, head, neck, and spinal, aesthetic surgical, and others. The market, by end user, has been segmented into hospitals and surgical centres, ambulatory care centres, and others.The Global Surgical Retractors Market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical retractors market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.     
The European Surgical Retractors Market has been segmented into Western Europe and Eastern Europe. The Western Europe surgical retractors market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.     The Surgical Retractors Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical retractors market in the Middle East & Africa has been segmented into the Middle East and Africa.     
Key players:Terumo Corporation, Henry Schein, INC., Johnson & Johnson, Medtronic, Becton, Dickinson and Company, Stryker Corporation, Globus Medical, INC., B. Braun Melsungen AG, Teleflex Incorporated, Integra Lifesciences Holdings Corporation, The Cooper Companies, INC., RTI Surgical, INC., Arthrex, Inc., Invuity, Inc., Medline Industries, Inc. are some of the prominent players in the global surgical retractors market.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global surgical retractors market owing to the high domestic income, and presence of major market players. According to the US Investments in Medical and Health Research and Development 2013-2015, a report by Research America, in 2015, total US medical and health R&D in the US was USD 158.7 billion.  
Europe is expected to hold the second largest position in the global surgical retractors market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).
The Surgical Retractors Market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing patient population and growing focus of major market players in the region.
The Middle East & Africa has the lowest share of the global surgical retractors market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.  

Browse Complete 100 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/surgical-retractors-market-7019

Detailed Table of Contents for Surgical Retractors Market
  1. Report Prologue
  2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
  1. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
  1. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
...Continued!
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/7019            

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Pipettes, Pipettors, and Accessories Market 2018 Market Challenge, Driver, Trends & Forecast to 2023

Market Scenario:
Global pipettes, pipettors, and accessories market is anticipated to register a healthy CAGR over the forecast period. The market held a market value of USD 1,350.0 million in 2017 and is projected to grow at a CAGR of 4.1% during the forecast period. A pipette is a laboratory tool used in laboratories to transfer a measurable amount of liquid from one container to another. These are small tubes or slender graduated tubes of glass or plastic used in laboratories to transfer a measurable volume of liquid. A pipettor is an instrument used to dispense liquid while pipetting. Factors driving the market growth are rising investment in research and development (R&D) activities, increasing demand for accuracy, productivity, and quality in healthcare companies, growing focus on improving lab throughputs, and mounting applications in life sciences and biomedical research, pharmaceutical, environmental, chemical, and food processing industries. For instance, as per the data published by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), in 2016 there were 6,861 drug entities in the preclinical regulatory phase that grew to 7,493 in 2017. In contrast, rapid development and launches of automatic and robotic-assisted liquid handling workstations are anticipated to restrain the market growth over the forecast period.
Segmentation:The Global Pipettes, Pipettors and Accessories Market has been segmented into product and end user.By product, the market has been segmented into pipettes, pipettors, and accessories. The pipettes segment is further categorized into beral/plastic/transfer/disposable pipettes, pasteur/glass pipettes/droppers, serological pipettes, volumetric/bulb pipettes, and others. The pipettors segment is sub-segmented into electronic pipettors and manual pipettors. These two pipettors are further separately categorized into single-channel pipettors and multichannel pipettors. Based on end user, the market has been segmented into hospitals, laboratories, academic & research institutes, pharmaceutical & biotechnology companies, and others.The Global Pipettes, Pipettors and Accessories Market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The pipettes, pipettors, and accessories market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
 The European Pipettes, Pipettors and Accessories Market has been segmented into Western Europe and Eastern Europe. The Western Europe pipettes, pipettors, and accessories market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.The Pipettes, Pipettors and Accessories Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The pipettes, pipettors, and accessories market in the Middle East & Africa has been segmented into the Middle East and Africa.
Global Pipettes, Pipettors, and Accessories Market, by Key Players:
  • Thermo Fisher Scientific Inc.
  • BRAND GMBH + CO KG
  • CAPP ApS
  • Thomas Scientific, Inc.
  • Corning Incorporated
  • Eppendorf AG
  • Gilson Incorporated
  • Hamilton Company
  • Greiner Bio-One International GmbH
  • INTEGRA Biosciences AG
  • The Lab Depot, Inc.
  • Sartorius AG
  • Socorex Isba S.A.
  • Nichiryo Co.,Ltd.
  • Mettler-Toledo International Inc.
Regional Market Summary
Geographically, in 2017, the Americas commanded the global pipettes, pipettors, and accessories market due to the presence of pipettes & pipettors manufacturers, advanced technology used in medical devices, rising spending on healthcare, and mounting demand for these lab supplies in the US and Canada.
 Europe is also expected to hold substantial market share over the forecast period due to the rise in research & development activities, the presence of favorable government policies related to healthcare infrastructure, the availability of well-developed lab facilities, and early adoption of novel technologies.
 Asia-Pacific is likely to witness fastest CAGR from 2018 to 2023 attributed to increased burden of various diseases coupled with considerable funding support for clinical research and rising interest in scientific & industrial research to create new business opportunities.
 The market in the Middle East & Africa would register the modest market growth rate from 2018 to 2023. Majority of the regional market is anticipated to be governed by the Middle East region due to increasing healthcare sector reforms.
 Browse Complete 120 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/pipettes-pipettors-and-accessories-market-7015

Detailed Table of Contents for Pipettes, Pipettors, and Accessories Market
  1. Report Prologue
  2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
  1. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
  1. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
...Continued!

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Blood Collection Market 2018 Share, Trend, Segmentation and Forecast to 2023

Market Scenario:
Global Blood Collection Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 7.46 million in 2017 and is projected to grow at a CAGR of 6.1% over the forecast period. Blood collection plays an important role in the treatment of patients. It persists as a diagnostic tool in laboratory medicine.In most of the cases, blood is usually collected to perform a variety of laboratory tests. Among all the types of blood collection devices, Capillary Blood Collection is simple and relatively painless procedure for clinical testing.
Rising demand for early diagnosis of chronic conditions is one of the key factors driving the blood collection market. According to the Centres for Disease Control and Prevention (CDC), in 2017 nearly 30.3 million people had diabetes out of which 23.1 million people were diagnosed with diabetes while 7.2 million people remain undiagnosed in the United States. Various other factors such as rising awareness about blood sampling, favourable medical device regulation, developing healthcare infrastructure, increasing research & development activities related to healthcare and favourable reimbursement and funding policies are also expected to propel the growth of the market. However, the injury caused during blood collection, blood contaminations, and other complications
can hinder the market growth over the forecast period. There are several potential complications related to blood collection procedure such as, Haematoma or excessive bleeding, arteriospasm or involuntary contraction of the artery, nerve damage, fainting or a vasovagal response, and others.
Segmentation:The Global Blood Collection Market has been segmented into type of blood collection, product, method, and end user.The market, on the basis of type of blood collection, has been segmented into capillary blood collection, venous blood collection, and vacuum blood collection.The market, by product, has been segmented into blood collection devices, blood collection tubes and collector, needles and syringes, warming devices, blood bags, lancets, and others. The blood collection tubes and collector segment is further classified as serum collection tubes, and plasma or whole blood collection tubes. The plasma or whole blood collection tubes segment includes EDTA tubes, heparin tubes, coagulation tubes, glucose tubes, and ESR tubes. The market, by method, has been segmented into automated blood collection and manual blood collection.
The market, by end user, has been segmented into hospitals & clinics, diagnostic centres and pathology laboratories, home diagnostics, blood banks, and others. The hospitals & clinics segment is anticipated to hold the largest market share owing to the increasing cases of chronic conditions. The diagnostic centres and pathology laboratories are expected to grow at the highest CAGR owing to the ongoing research on better blood sampling approaches.The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The blood collection market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European Blood Collection Market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The Blood Collection Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The blood collection market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players:BD, Medtronic, Terumo, Haemonetics, Fresenius, Nipro Medical, Kawasumi Laboratories, F.L. Medical, Greiner Holding, Grifols, B. Braun Melsungen AG, Thermo Fisher Scientific Inc., HTL-STREFA S.A., Sarstedt AG & Co and others are some of the key players in the global blood collection market.
Regional Market Summary 
Geographically, the Americas is anticipated to dominate the global blood collection market owing to rising healthcare expenditure, increasing cases of chronic conditions and technological advancements in blood collection.
According to the data suggested by Centres for Disease Control and Prevention (CDC) in 2017, 38,739 people received an HIV diagnosis in the US. An antigen/antibody test performed on blood from a vein can usually detect HIV infection 18 to 45 days after an exposure.
Europe is expected to hold the second largest position in the global blood collection market. The market growth in this region is attributed to the government funding and improvement in research & development activities.
The blood collection market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the awareness regarding use of sterile devices for blood collection and rising healthcare spending. According to the World Bank Group, India spent 3.89% of its Gross Domestic Product (GDP) on health.
The Middle East & Africa are expected to hold the least share of the market. The market growth in this region is expected to be driven by rising awareness about blood collection techniques and developing healthcare infrastructure.
Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/blood-collection-market-7013
Detailed Table of Contents for Blood Collection Market
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
...Continued!

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:

Friday, 11 January 2019

Connective Tissue Disease Market Analysis 2018 (By Segment, Key Players and Applications) and Forecasts To 2023

Developments in the treatment of connective tissue diseases (CTDs) have been improved considerably, and the global connective tissue diseases market is slated to grow at a promising CAGR of 11.5% over the forecast period of 2017-2023. The cause of the disease is unknown and there's no cure for connective tissue disease yet, but medications are present to manage the signs and symptoms. CTDs include a large number of disorders which can affect different organs of the body. There is broad variability in disorders among patient suffering from CTDs.
It is estimated that connective tissue disease market is expected to grow at a CAGR 11.5% during the forecast period of 2017-2023.
A significant increase in the research and development efforts to find treatment and cure for CTDs have aided the growth of the market. Various therapy trials are underway which have been able to identify promising novel approaches to treat CTDs and are expected to boost the growth of the market. Rising prevalence of CTDs across the globe, especially in women has propelled the growth of the market. Additionally, support from governments across the world along with funds for R&D from the private industry is also a key driver of the growth of the market. With the increase in awareness and acceptance among the general population about connective tissue diseases, the diagnosed and drug-treated population will increase which will positively impact the market. Rising expenditure on healthcare, high unmet medical needs of the current treatment and growing prevalence of CTDs in Asia and Africa are expected to promote the growth of the market.  However, the growth of the market might be hindered by lack of a knowledgeable workforce, inadequate research and development infrastructure, lack of funds in middle and low-income countries.
Regional Analysis
The Americas dominate the connective tissue disease market owing to the rising awareness among people, and increasing healthcare expenditure. As per the facts suggested by the Centers for Disease Control and Prevention (CDC), out of the total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States.
Europe holds the second position in the connective tissue disease market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe.
Asia Pacific is the fastest growing market connective tissue disease, owing to a huge patient pool, developing healthcare technology, and rising healthcare expenditure in some countries within this region. According to the Australian Institute of Health and Welfare, in the years 2015 to 2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than expenditure of 2014–15.
The Middle East & Africa has the lowest market for connective tissue disease due to lack of technical knowledge and poor medical facilities. 
Key Players
Some of key the players in the market are Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche Ltd, Pfizer, AutoImmune Inc., Johnson & Johnson, Amgen Inc., AstraZeneca, Eli Lilly and Company, Biogen, LUPIN, and others.
Segmentation
The connective tissue disease market is segmented on the basis of diagnosis, treatment, and end-user.
On the basis of diagnosis, market is segmented into physical examination, X-ray examination, ANA (Antinuclear Antibody Test), and others.
On the basis of treatment, market is classified into non-steroidal anti-inflammatory drugs (NSAIDs), cortisone drugs/steroids, antimalarial drugs, cytotoxic drugs, and others
On the basis of end-user, market is segmented into hospital, diagnostic clinics, and others.

Browse Complete 85  Pages Premium Research Report Enabled with 66 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/connective-tissue-disease-market-4977
Detailed Table of Contents:
  1. Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
  1. Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research
  1. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
...Continued!
         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:
Subscribe to: Posts (Atom)